Disclosure of trade

With reference to disclosure requirements set out in section 4-2 of the Norwegian Securities Trading Act, Lars Hjarrand, a primary insider as Chief Financial Officer in Navamedic ASA, has on December 20th, 2019 acquired 132.882 shares in Navamedic ASA at an average price of 16,5564 NOK. After this transaction Lars Hjarrand owns 132.882 shares in the company.